JG
CELU icon

Jefferies Group’s Celularity CELU Stock Holding History

Jefferies Group’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,500
Closed -$165K – 1664
2020
Q4 		$165K Sell
1,500
-6,000
-80% -$638K ﹤0.01% 1403
2020
Q3 		$788K Sell
7,500
-12,500
-63% -$1.29M 0.01% 864
2020
Q2 		$2.04M Sell
20,000
-12,345
-38% -$1.23M 0.02% 544
2020
Q1 		$3.17M Buy
32,345
+974
+3% +$96.4K 0.04% 481
2019
Q4 		$3.14M Buy
+31,371
New +$3.11M 0.02% 786

Other funds holding CELU

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Jefferies Group's CELU Position: Q1 2021 in Review

Jefferies Group sold out of Celularity (CELU) in Q1 2021, closing a stake of 1,500 shares — an estimated $165K sold.

Jefferies Group first reported a position in CELU in Q4 2019 and held it in 5 quarters. The position peaked at $3.17M in Q1 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

  • Jefferies Group reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
  • Jefferies Group sold 1,500 Celularity shares in Q1 2021, an estimated $165K.
  • Jefferies Group first reported a position in Celularity in Q4 2019 and held it in 5 quarters.
  • Jefferies Group's Celularity position peaked at $3.17M in Q1 2020.
  • 63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.